Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 34201-34250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06092411
Effects of CBT and BLT in Youth With Unipolar Depression and Evening Chronotype
NARecruiting
162 participants
Started: Oct 31, 2023 · Completed: Oct 20, 2026
2 conditions2 sponsors1 location
NCT05866107
App and Body Fat Scale in the Management of Overweight Patients
NARecruiting
204 participants
Started: Oct 31, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT06041477
Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC
PHASE3Recruiting
540 participants
Started: Oct 31, 2023 · Completed: Jul 31, 2030
3 conditions4 sponsors1 location
NCT05995028
Universal 4SCAR7U Targeting CD7-positive Malignancies
PHASE1Recruiting
30 participants
Started: Oct 31, 2023 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT06102837
Tumor Vaccines for Solid Tumors
N/ARecruiting
340 participants
Started: Oct 31, 2023 · Completed: Oct 31, 2027
2 conditions1 sponsor1 location
NCT06079125
PFDD Versus PFDRT in Chiari Decompression Surgery
NARecruiting
352 participants
Started: Oct 31, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06031662
Accelerated, Theta-burst Stimulation for the Treatment of Post-concussion Syndrome
NARecruiting
26 participants
Started: Oct 31, 2023 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT06010888
Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC
PHASE2Recruiting
92 participants
Started: Oct 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06419231
Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms
NARecruiting
105 participants
Started: Oct 31, 2023 · Completed: Jul 15, 2025
1 condition2 sponsors1 location
NCT04939623
Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
PHASE2Recruiting
40 participants
Started: Oct 31, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06099314
Fruquintinib in the Cross-line Treatment of Refractory mCRC
N/ARecruiting
36 participants
Started: Oct 31, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor3 locations
NCT06206369
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression
N/ARecruiting
11,000 participants
Started: Oct 31, 2023 · Completed: May 1, 2029
2 conditions13 sponsors6 locations
NCT06072378
The Computational and Neural Mechanisms Linking Decision-making and Memory in Humans
NARecruiting
50 participants
Started: Oct 31, 2023 · Completed: Sep 1, 2028
1 condition2 sponsors1 location
NCT06085092
Open vs. Blind Weighing Study In Adolescents and Young Adult With Eating Disorders
NARecruiting
70 participants
Started: Oct 31, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06072989
Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors
PHASE1Recruiting
24 participants
Started: Oct 31, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors2 locations
NCT05970497
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
240 participants
Started: Oct 31, 2023 · Completed: Jul 31, 2027
4 conditions1 sponsor15 locations
NCT05995015
4SCAR19U T Cells Targeting B Cell Malignancies
PHASE1Recruiting
30 participants
Started: Oct 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06548256
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
NARecruiting
400 participants
Started: Oct 31, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06032975
PRO for Fighting FT in Ovarian Cancer
N/ARecruiting
240 participants
Started: Oct 30, 2023 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT06129162
Pain Perception Comparison of Computerized vs Conventional Injection Methods
NARecruiting
120 participants
Started: Oct 30, 2023 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT06074614
Neural Control of Breathing in Parkinson's Disease
N/ARecruiting
30 participants
Started: Oct 30, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06915896
Predictive Variables of Outcome in Subjects With Chronic Rachialgia Referred to Different Pathways of Physiotherapy.
N/ARecruiting
200 participants
Started: Oct 30, 2023 · Completed: May 1, 2026
2 conditions1 sponsor1 location
NCT06399926
Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir
N/ARecruiting
64 participants
Started: Oct 30, 2023 · Completed: Jun 30, 2027
2 conditions3 sponsors1 location
NCT06014801
Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients
PHASE2/PHASE3Recruiting
400 participants
Started: Oct 30, 2023 · Completed: Sep 30, 2026
1 condition8 sponsors9 locations
NCT06302972
Effects of IASTM Along With Comprehensive Corrective Exercise Program in Upper Cross Syndrome.
NARecruiting
44 participants
Started: Oct 30, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06054542
Turkish Version of Digital Eye Strain Questionnaire (DESQ)
N/ARecruiting
130 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2024
5 conditions1 sponsor1 location
NCT05960799
Catheter Over Needle (CON) vs Catheter Through Needle (CTN).
NARecruiting
70 participants
Started: Oct 30, 2023 · Completed: Jul 1, 2024
1 condition1 sponsor1 location
NCT06117007
Effects of Betalains on Cardiovascular Health and Quality of Life
NARecruiting
42 participants
Started: Oct 30, 2023 · Completed: Aug 15, 2024
4 conditions2 sponsors1 location
NCT05793151
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
NARecruiting
532 participants
Started: Oct 30, 2023 · Completed: Mar 30, 2028
5 conditions2 sponsors4 locations
NCT06090890
Anti-inflammatory Therapy for Recurrent In-stent Restenosis
PHASE4Recruiting
252 participants
Started: Oct 30, 2023 · Completed: Oct 29, 2027
1 condition1 sponsor4 locations
NCT06081673
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC
PHASE2Recruiting
72 participants
Started: Oct 30, 2023 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT04349059
The Impact of Dietary Pattern on Erectile Function
NARecruiting
46 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05849337
The Lóa Study: a Brief Digital Intervention for Women with Intrusive Memories in the SAGA Cohort
NARecruiting
380 participants
Started: Oct 30, 2023 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT07114276
Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients
N/ARecruiting
110 participants
Started: Oct 30, 2023 · Completed: Jan 31, 2026
4 conditions2 sponsors1 location
NCT06102928
A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation
NARecruiting
30 participants
Started: Oct 30, 2023 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT06041282
Conservative Treatment of Early Adhesive Capsulitis
NARecruiting
300 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05943535
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
PHASE3Recruiting
698 participants
Started: Oct 30, 2023 · Completed: Nov 30, 2027
2 conditions1 sponsor138 locations
NCT06072300
Effects of Physical Activity Calorie Equivalent Labelling on Hot Drink Vending Transactions
PHASE3Recruiting
20,000 participants
Started: Oct 30, 2023 · Completed: May 31, 2024
3 conditions1 sponsor1 location
NCT05942885
Hypnosis: a Path to Appeasement
NARecruiting
50 participants
Started: Oct 30, 2023 · Completed: Jul 30, 2026
1 condition1 sponsor1 location
NCT06130722
First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study
PHASE1Recruiting
18 participants
Started: Oct 30, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor3 locations
NCT06477666
Description of the Impact of the Modelo Sentido's® on Adaptive Behaviors in Children With Autism
N/ARecruiting
75 participants
Started: Oct 30, 2023 · Completed: Jun 27, 2025
3 conditions1 sponsor1 location
NCT06140732
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
PHASE2Recruiting
30 participants
Started: Oct 30, 2023 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT06030258
IN10018 Combination Therapy in Treatment-naïve ES-SCLC
PHASE1/PHASE2Recruiting
120 participants
Started: Oct 30, 2023 · Completed: Dec 24, 2025
1 condition1 sponsor3 locations
NCT06072703
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
NARecruiting
29 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05978622
Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant
N/ARecruiting
327 participants
Started: Oct 30, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor54 locations
NCT05657548
Study of Sagittal Pelvic Statics in the Sitting Position in Children With Cerebral Palsy
N/ARecruiting
100 participants
Started: Oct 30, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05416476
Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine
PHASE3Recruiting
288 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor19 locations
NCT06189950
Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE
NARecruiting
200 participants
Started: Oct 30, 2023 · Completed: Oct 30, 2026
3 conditions1 sponsor1 location
NCT06509308
Illness Expectations in COPD
N/ARecruiting
200 participants
Started: Oct 30, 2023 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT06123936
Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician
NARecruiting
8,400 participants
Started: Oct 30, 2023 · Completed: Feb 28, 2025
1 condition1 sponsor1 location